Database

Startups

Main Industry
Health Care
Main Product/Service
1. Out-licensing of innovative drug products, including the AN-8 series, a novel therapy designed to reverse cancer drug resistance, and other pharmaceuticals.
2. Utilizing proprietary technology platforms — (1) the HTPVAC drug development platform and (2
Founded Year
2017
Unified Business No.
52805302
Status
Active
Number of Employees
4
Total Paid-in Capital
25,014,700 (NT$)
Location of Company
Taiwan , Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
About the Company
Acura NanoMedicine is one of the few dual-platform technology new drug companies in the world. We integrate AI big data drug discovery platform and nano drug delivery system platform to develop a series of nano anticancer drugs (AN-8 series & others) that



More ↓

Similar Companies

HONYA MEDICAL CO., LTD.

1. Cell Therapy
2. Clinical trial
3. MCRcI®
4. MiSaver®

TRUST BIO-SONICS INC.

1. Ultrasound Imaging Agents
2. Ultrasound-Mediated Targeted Delivery

TAIWAN BIO THERAPEUTICS INC.

Leveraging the FAST CGT platform to enhance the specificity, persistence, and stability of regulatory T cells, improving their ability to restore immune tolerance and suppress inflammation as a targeted alternative to non-selective, high-risk immunosuppre